You have 9 free searches left this month | for more free features.

BRCA

Showing 1 - 25 of 916

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • blood sample for BRCA2 mutation detection
    • (no location specified)
    Jun 1, 2023

    BRCA and NACT in TNBC Patients

    Completed
    • Triple-Negative Breast Cancer
    • BRCA1/2 genetic testing
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Feb 20, 2023

    Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

    Not yet recruiting
    • Breast Cancer
    • Questionnaires
    • Communication of the results of the BRCA1/2 ultra rapid test
    • (no location specified)
    Oct 26, 2023

    Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

    Enrolling by invitation
    • Breast Cancer
    • +7 more
    • Dnipro, Ukraine
    • +1 more
    Jun 17, 2023

    Germline BRCA-mutated HER2-negative Breast Cancer Trial in Beijing (Camrelizumab+Fluzoparib)

    Enrolling by invitation
    • Germline BRCA-mutated HER2-negative Breast Cancer
    • Beijing, Beijing, China
      Breast Cancer, Peking University People's Hospital
    Nov 14, 2022

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • +7 more
    • (no location specified)
    Aug 1, 2022

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Quality of Sexual Function in BRCA Mutated Women

    Recruiting
    • BRCA Mutation
    • +3 more
    • SFQ28 Questionnaire
    • Brescia, BS, Italy
      Federico Ferrari
    Jul 10, 2022

    TNBC - Triple-Negative Breast Cancer Trial in Nanjing (Fluzoparib+Paclitaxel, Epirubicin+Cyclophosphamide)

    Recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Nanjing, Jiangsu, China
      JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
    Apr 27, 2023

    Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

    Not yet recruiting
    • Ovarian Cancer
    • +4 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Cetntre
    Sep 25, 2023

    BRCA1/2 Flu Vaccine

    Active, not recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Seasonal influenza vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 16, 2022

    Endocrine Disruptors and Life STILe in Breast Cancer Development

    Recruiting
    • Breast Cancer
    • +5 more
      • Roma, Italy
        Alessandra Fabi
      Feb 25, 2023

      Breast Cancer Trial in Los Angeles (Pembrolizumab, Olaparib)

      Active, not recruiting
      • Breast Cancer
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Feb 1, 2023

      Ovarian Cancer Trial (Huaier granule)

      Not yet recruiting
      • Ovarian Cancer
      • Huaier granule
      • (no location specified)
      Feb 28, 2023

      Breast Cancer With or Without BRCA Mutation

      Recruiting
      • Breast Cancer
      • Androgen receptor status and BRCA mutation
      • Varanasi, UP, India
        Banaras Hindu University
      Jun 2, 2022

      Breast Cancer After Ovarian Cancer During and/or After Therapy:

      Recruiting
      • BRCA-Associated Breast Carcinoma
      • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
      • Rome, RM, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Mar 9, 2023

      Breast Tumor Female Trial in United Kingdom (Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform,

      Active, not recruiting
      • Breast Neoplasm Female
      • Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform
      • Digital Delivery of Genetic Test Results via the BRCA-DIRECT Platform
      • Manchester, England, United Kingdom
      • +4 more
      Aug 12, 2022

      Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

      Not yet recruiting
      • Metastatic Solid Tumor
      • +4 more
      • San Francisco, California
        University of California, San Francisco
      Jan 12, 2023

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

      Active, not recruiting
      • BRCA1 Gene Mutation
      • +5 more
      • Durvalumab
      • +3 more
      • Buffalo, New York
      • +1 more
      Jan 20, 2023